Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo D Müller

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Methods in Enzymology|September 15, 2012
Ghrelin in the control of energy, lipid, and glucose metabolismKristy M Heppner, Timo D Müller, Jenny Tong, et al.
Peptides|February 8, 2018
Gut hormone polyagonists for the treatment of type 2 diabetesSara J Brandt, Anna Götz, Matthias H Tschöp, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 4, 2024
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and DiabetesRobert M Gutgesell, Rubén Nogueiras, Matthias H Tschöp, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 4, 2020
Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment StrategiesHeiko Krude, Heike Biebermann, Markus Schuelke, et al.
Biomedicines|April 3, 2021
Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and HumansGünter A Müller, Andreas Lechner, Matthias H Tschöp, et al.
Diabetes|October 30, 2015
Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin SensitivityTobias Wiedemann, Maximilian Bielohuby, Timo D Müller, et al.
Comprehensive Physiology|December 20, 2019
Gut Peptide Agonism in the Treatment of Obesity and DiabetesGerald Grandl, Aaron Novikoff, Richard DiMarchi, et al.
Child and Adolescent Psychiatric Clinics of North America|November 19, 2008
Leptin-mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implicationsTimo D Müller, Manuel Föcker, Kristian Holtkamp, et al.
Handbook of Experimental Pharmacology|April 24, 2015
Current and Emerging Treatment Options in Diabetes CareChristoffer Clemmensen, Timo D Müller, Brian Finan, et al.
Nature Reviews. Drug Discovery|May 13, 2026
The evolving landscape of obesity pharmacotherapyJonas Petersen, Brian Finan, Valdemar B I Johansen, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Methods in Enzymology|September 15, 2012
Ghrelin in the control of energy, lipid, and glucose metabolismKristy M Heppner, Timo D Müller, Jenny Tong, et al.
Peptides|February 8, 2018
Gut hormone polyagonists for the treatment of type 2 diabetesSara J Brandt, Anna Götz, Matthias H Tschöp, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 4, 2024
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and DiabetesRobert M Gutgesell, Rubén Nogueiras, Matthias H Tschöp, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 4, 2020
Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment StrategiesHeiko Krude, Heike Biebermann, Markus Schuelke, et al.
Biomedicines|April 3, 2021
Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and HumansGünter A Müller, Andreas Lechner, Matthias H Tschöp, et al.
Diabetes|October 30, 2015
Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin SensitivityTobias Wiedemann, Maximilian Bielohuby, Timo D Müller, et al.
Comprehensive Physiology|December 20, 2019
Gut Peptide Agonism in the Treatment of Obesity and DiabetesGerald Grandl, Aaron Novikoff, Richard DiMarchi, et al.
Child and Adolescent Psychiatric Clinics of North America|November 19, 2008
Leptin-mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implicationsTimo D Müller, Manuel Föcker, Kristian Holtkamp, et al.
Handbook of Experimental Pharmacology|April 24, 2015
Current and Emerging Treatment Options in Diabetes CareChristoffer Clemmensen, Timo D Müller, Brian Finan, et al.
Nature Reviews. Drug Discovery|May 13, 2026
The evolving landscape of obesity pharmacotherapyJonas Petersen, Brian Finan, Valdemar B I Johansen, et al.
Pageof 19